Electrophysiological effects of S 16257, a novel sino-atrial node modulator, on rabbit and guinea-pig cardiac preparations: comparison with UL-FS 49

C Thollon, C Cambarrat, J Vian, J F Prost, J L Peglion, J P Vilaine, C Thollon, C Cambarrat, J Vian, J F Prost, J L Peglion, J P Vilaine

Abstract

1. S 16257 is a new bradycardic agent. Its electropharmacological profile has been compared to that of the known bradycardic compound UL-FS 49 (Zatebradine). Intracellular recordings of action potentials (APs) were performed with conventional glass microelectrodes. 2. In the rabbit isolated sino-atrial node (SAN) tissue, S 16257 and UL-FS 49 (1 microM, 3 microM and 10 microM) were equipotent in slowing spontaneous APs firing predominantly by decreasing the rate of diastolic depolarization (at 3 microM, -23.8 +/- 3.9% and -27.9 +/- 2.6%, respectively). For the two compounds a maximal effect was obtained at 3 microM. In these preparations, action potential duration at 50% of total repolarization (APD50) was more affected by UL-FS 49 than S 16257 at any concentration tested (at 3 microM, +8.9 +/- 2.9% and +29.1 +/- 3.7% for S 16257 and UL-FS 49, respectively; P < or = 0.01). 3. To estimate the direct effects on AP duration, driven cardiac preparations were exposed to these agents. In guinea-pig papillary muscles, paced at a frequency of 1 Hz, increasing concentrations of S 16257 or UL-FS 49 (0.1 to 10 microM, 30 min exposure for each concentration) slightly prolonged AP repolarization. This prolongation was more marked for UL-FS 49 (at 1 microM, +6.1 +/- 0.6% and +11.2 +/- 1.3% elevation of APD50, for S 16257 and UL-FS 49, respectively). 4. Application of UL-FS 49 (3 microM) to rabbit Purkinje fibres, triggered at a frequency of 0.25 Hz, induced a marked prolongation of APD50 and APD90 (+149.4 +/- 51.2% and +86.0 +/- 15.4%, respectively). S 16257 (3 MicroM) induced only a weak prolongation of AP (+ 14.1 +/- 5.0% and + 14.8 +/- 3.3% for APD50 and APD90, respectively) significantly smaller than in the case of UL-FS 49.5. These results show that S 16257 slows the rate of spontaneous AP firing in isolated SAN mainly by a reduction of the diastolic depolarization of the cells, which suggests an inhibition of the pace-maker current (If). S 16257 and UL-FS 49 are equipotent in their bradycardic effect but S 16257 is more specific as it induces less increase in myocardial repolarization time.

References

    1. Am J Cardiol. 1968 Sep;22(3):328-36
    1. Am J Physiol. 1956 May;185(2):355-64
    1. Am J Cardiol. 1982 Nov;50(5):1082-6
    1. Circulation. 1984 May;69(5):1013-25
    1. Eur J Pharmacol. 1984 Sep 3;104(1-2):9-18
    1. J Pharmacol Exp Ther. 1985 Mar;232(3):817-25
    1. J Cardiovasc Pharmacol. 1986 Jul-Aug;8(4):791-7
    1. Naunyn Schmiedebergs Arch Pharmacol. 1986 Dec;334(4):540-3
    1. Int J Cardiol. 1987 Mar;14(3):343-54
    1. Eur Heart J. 1987 Dec;8 Suppl L:35-42
    1. Eur Heart J. 1987 Dec;8 Suppl L:53-9
    1. Eur Heart J. 1987 Dec;8 Suppl L:7-15
    1. Eur Heart J. 1987 Dec;8 Suppl L:91-8
    1. Circ Res. 1988 Aug;63(2):286-305
    1. Br J Pharmacol. 1988 May;94(1):55-64
    1. Am Heart J. 1989 Aug;118(2):361-80
    1. Circulation. 1989 Oct;80(4):983-93
    1. Naunyn Schmiedebergs Arch Pharmacol. 1990 Apr;341(4):331-40
    1. Cardiol Clin. 1990 Aug;8(3):393-409
    1. Eur J Pharmacol. 1990 Oct 9;187(2):241-56
    1. J Pharmacol Exp Ther. 1991 Jan;256(1):318-24
    1. J Cardiovasc Pharmacol. 1990 Dec;16(6):917-23
    1. Cardiovasc Drugs Ther. 1989 Jun;3 Suppl 1:257-70
    1. J Physiol. 1991 Mar;434:23-40
    1. Cardiovasc Drugs Ther. 1992 Feb;6(1):59-65
    1. Eur J Pharmacol. 1992 Dec 8;229(1):55-62
    1. Physiol Rev. 1993 Jan;73(1):197-227
    1. Cardiovasc Res. 1992 Nov;26(11):1021-9
    1. Therapie. 1992 May-Jun;47(3):193-8
    1. Cardiovasc Res. 1993 May;27(5):861-7
    1. J Cardiovasc Pharmacol. 1982 Mar-Apr;4(2):213-20

Source: PubMed

3
Abonnere